Severe cardiomyopathy in human Chagas' disease is associated with a strong Th1-specific immune response driven by IFN-gamma production from T lymphocytes, whereas IL-10 from monocytes may regulate the immune response in indeterminate patients.
Answers are grounded in this paper and cite their sources.
Immune phenotyping may aid Chagas risk stratification; leaves open whether targeting IFN-gamma or IL-10 alters cardiomyopathy progression.
The role of interleukin 10 (IL-10) and gamma interferon (IFN-gamma) on the development of pathology in human Chagas' disease was investigated. Two categories of patients, low and high producers of IFN-gamma, were identified based on the levels of secretion of this cytokine in the supernatant of peripheral blood mononuclear cell (PBMC) cultures. Eighty-three percent of the patients presenting with cardiac disease (CARD) of different degrees and 59% of the patients with the indeterminate form of disease (IND) were identified as high IFN-gamma producers. PBMC from IND patients classified as low IFN-gamma producers secreted significantly higher amounts of IL-10 than did those from other groups. Flow cytometry analysis demonstrated that in PBMC from the IND group, the majority of the IL-10-producing cells were monocytes (CD14(High+) cells), whereas in the CARD group, the major sources of IFN-gamma were T lymphocytes (CD3(+) CD4(+) cells). These results suggest an association between the production of IFN-gamma by CD3(+) CD4(+) cells and morbidity in Chagas' disease, whereas the production of IL-10 by macrophages/monocytes leads to regulation of the immune response in IND patients. We hypothesize that an exacerbated production of IFN-gamma against Trypanosoma cruzi antigens favors the development of a strong Th1 response in CARD patients, which leads to progression of heart disease.
No takes yet. Share an insight, caveat, or question.
Gomes et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: